Schedule 13G ownership disclosure
Beam Therapeutics Inc
COMMON STOCK · CUSIP: 07373V105
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- FMR LLC
Shares: 10,042,092.33 · Class: 10.1%
- Abigail P. Johnson
Shares: 10,042,092.33 · Class: 10.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-25-001019
- Form type
- SCHEDULE 13G/A
- Filer
- Beam Therapeutics Inc.
- CIK
- CIK 1745999
- Filed
- Apr 02, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership